Patent Assignment
Reel/Frame 065045/0730
Release of Security Interest in Patents Recorded at Reel 026177/Frame 0874
Recorded: 2023-09-27
Pages: 10
Assignor
TANG CAPITAL PARTNERS, LP
Executed: 2023-09-27
Assignee
HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.)
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(15)
Polymers with Controlled Physical State and Bioerodibility
Patent:
5,968,543 →
Application:
08/986,035 →
Peg-Poe, Peg-Poe-Peg, and Poe-Peg-Poe Block Copolymers
Patent:
5,939,453 →
Application:
09/090,648 →
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
Bioerodible Polyorthoesters from Dioxolane-Based Diketene Acetals
Degradable Polyacetal Polymers
Block Copolymers Based on Poly(Ortho Esters) Containing Amine Groups
Method of Preparing Di(Ketene Acetals)
Bioerodible Poly (Orthoesters)from Dioxolane-Based Diketene Acetals
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Bioerodible Poly(Ortho Esters) from Dioxane-Based Di(Ketene Acetals), and Block Copolymers Containing Them
Peg-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions
PEG-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions
Application:
12/256,408 →
Publication:
US 2009/0048151
Long-Acting Injectable Analgesic Formulations for Animals
Application:
12/505,457 →
Publication:
US 2010/0120811
Methods for Enhancing Stability of Polyorthoesters and Their Formulations
Application:
12/635,681 →
Publication:
US 2010/0152227
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 3, 2014
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 032153/0273 →
Security Interest
Aug 30, 2016
From: HERON THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS, LP
Reel/Frame 039590/0239 →
Release of Security Interest
Mar 25, 2021
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC.
Reel/Frame 055725/0523 →
Intellectual Property Security Agreement
Aug 9, 2023
From: HERON THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 064546/0453 →